Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lowe

Showing results (721-730 of 755) with videos related to

Pageof 76
Sort By:
Frontiers in Immunology|October 10, 2022
Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experienceAdrian M Shields, Susan Tadros, Adam Al-Hakim, et al.
Nucleic Acids Research|February 8, 2025
R2DT: a comprehensive platform for visualizing RNA secondary structureHolly McCann, Caeden D Meade, Loren Dean Williams, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
R2DT: A COMPREHENSIVE PLATFORM FOR VISUALISING RNA SECONDARY STRUCTUREHolly McCann, Caeden D Meade, Loren Dean Williams, et al.
Nucleic Acids Research|February 19, 2025
R2DT: a comprehensive platform for visualizing RNA secondary structureHolly McCann, Caeden D Meade, Loren Dean Williams, et al.
Journal of Clinical Immunology|April 14, 2022
SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD StudyAdrian M Shields, Sian E Faustini, Harriet J Hill, et al.
Phytopathology|February 8, 2024
Open Access and Reproducibility in Plant Pathology Research: Guidelines and Best PracticesNiklaus J Grünwald, Clive H Bock, Jeff H Chang, et al.
Journal of Cheminformatics|October 18, 2011
Open Data, Open Source and Open Standards in chemistry: The Blue Obelisk five years onNoel M O'Boyle, Rajarshi Guha, Egon L Willighagen, et al.
The Journal of Infection|May 21, 2025
Monitoring the emergence of resistance with sotrovimab in immunocompromised patients with COVID-19: LUNAR studyJudith Breuer, Myriam Drysdale, Jill Walker, et al.
Frontiers in Immunology|June 20, 2022
Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD StudyAdrian M Shields, Sian E Faustini, Harriet J Hill, et al.
The Journal of Infection|March 25, 2024
Novel antivirals for severe enterovirus infection in immunocompromised hosts; A case seriesAndrea Meinhardt, Liam Reilly, Marios Kaliakatsos, et al.
Pageof 76

Showing results (721-730 of 755) with videos related to

Sort By:
Pageof 76
Frontiers in Immunology|October 10, 2022
Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experienceAdrian M Shields, Susan Tadros, Adam Al-Hakim, et al.
Nucleic Acids Research|February 8, 2025
R2DT: a comprehensive platform for visualizing RNA secondary structureHolly McCann, Caeden D Meade, Loren Dean Williams, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
R2DT: A COMPREHENSIVE PLATFORM FOR VISUALISING RNA SECONDARY STRUCTUREHolly McCann, Caeden D Meade, Loren Dean Williams, et al.
Nucleic Acids Research|February 19, 2025
R2DT: a comprehensive platform for visualizing RNA secondary structureHolly McCann, Caeden D Meade, Loren Dean Williams, et al.
Journal of Clinical Immunology|April 14, 2022
SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD StudyAdrian M Shields, Sian E Faustini, Harriet J Hill, et al.
Phytopathology|February 8, 2024
Open Access and Reproducibility in Plant Pathology Research: Guidelines and Best PracticesNiklaus J Grünwald, Clive H Bock, Jeff H Chang, et al.
Journal of Cheminformatics|October 18, 2011
Open Data, Open Source and Open Standards in chemistry: The Blue Obelisk five years onNoel M O'Boyle, Rajarshi Guha, Egon L Willighagen, et al.
The Journal of Infection|May 21, 2025
Monitoring the emergence of resistance with sotrovimab in immunocompromised patients with COVID-19: LUNAR studyJudith Breuer, Myriam Drysdale, Jill Walker, et al.
Frontiers in Immunology|June 20, 2022
Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD StudyAdrian M Shields, Sian E Faustini, Harriet J Hill, et al.
The Journal of Infection|March 25, 2024
Novel antivirals for severe enterovirus infection in immunocompromised hosts; A case seriesAndrea Meinhardt, Liam Reilly, Marios Kaliakatsos, et al.
Pageof 76